Global Lymphoma Treatment Market was valued at $28 billion in 2025 and is projected to reach $63 billion by 2035, growing at a CAGR of 8.50% during the forecast period (2026–2035) driven by rising cancer prevalence, advancements in targeted therapies, and increasing healthcare investments. A key macro driver accelerating market growth is the rising global cancer burden. According to the World Health Organisation, cancer accounted for nearly 10 million deaths globally in 2022, making it one of the leading causes of mortality worldwide. Additionally, the International Agency for Research on Cancer estimates that global cancer cases are expected to rise to over 35 million by 2050, reflecting a significant increase in oncology treatment demand, including lymphoma therapies.

Legal hold software market was valued at $4.0 billion in 2025 and is projected to reach $10.8 billion by 2035, growing at a CAGR of 10.5% during the forecast period (2026–2035). The market growth is primarily driven by the increasing volume of digital data, rising regulatory compliance requirements, and growing need for efficient litigation and investigation processes across enterprises. A key macro driver supporting market expansion is the rapid increase in global internet penetration and enterprise digitalization. According to the International Telecommunication Union (ITU), approximately 6 billion people globally are using the internet in 2025, accounting for nearly 74% of the world population. This widespread digital adoption has significantly increased the volume of emails, enterprise files, and cloud-based communications that organizations must manage and preserve. Additionally, Eurostat reports that over 52% of enterprises in the European Union are using cloud computing services, reflecting a strong shift toward digital business operations.

Land mobile radio system market was valued at $21.5 billion in 2025 and is projected to reach $41.5 billion by 2035, growing at a CAGR of 6.80% during the forecast period (2026–2035). The market growth is primarily driven by increasing investments in public safety infrastructure, rising demand for secure communication systems, and the expansion of mission-critical communication networks across transportation, utilities, and defense sectors. A key macro driver supporting market expansion is the growing emphasis on emergency communication systems globally. According to the International Telecommunication Union (ITU), more than 90% of countries have established national emergency telecommunication frameworks, highlighting the critical importance of reliable communication infrastructure during disasters and emergencies.

The global insomnia treatment market was valued at $3.10 billion in 2025 and is projected to reach $4.85 billion by 2035, growing at a CAGR of 4.6% during the forecast period (2026–2035). The increasing prevalence of sleep disorders driven by rising stress levels, mental health conditions, and lifestyle changes is a major factor supporting market growth. According to the World Health Organization, approximately 1 in 8 people globally live with a mental disorder, which significantly contributes to insomnia incidence. Insomnia treatment solutions, including pharmacological therapies and digital cognitive behavioural therapy (CBT-I), play a critical role in improving sleep quality, reducing long-term health risks, and enhancing patient outcomes. The market is witnessing steady adoption of orexin receptor antagonists and digital therapeutics as healthcare providers shift toward targeted and non-invasive treatment approaches.

Industrial hose market was valued at $14.36 billion in 2025 and is projected to reach $21.80 billion by 2035, growing at a CAGR of 4.26% during the forecast period (2026–2035). The growing demand for fluid transfer systems across industrial sectors is a key macro driver supporting market growth. According to the International Energy Agency, global oil demand reached over 102 million barrels per day in 2023, reflecting sustained expansion in upstream and downstream oil & gas activities. Industrial hoses play a critical role in transferring oil, chemicals, water, and gases under varying pressure and temperature conditions, making them essential in energy infrastructure. Increasing investments in oil & gas exploration, refining, and chemical processing are significantly boosting demand for durable and high-performance industrial hose systems.

Imatinib drugs market was valued at $1.80 billion in 2025 and is projected to reach $2.52 billion by 2035, growing at a CAGR of 4.3% during the forecast period (2026–2035). The market growth is primarily driven by the rising global burden of cancer, particularly hematological malignancies. According to the World Health Organization, cancer accounted for nearly 10 million deaths worldwide in 2022, with leukemia representing a significant share of cases. Imatinib remains a first-line targeted therapy for Chronic Myeloid Leukemia (CML) and other rare cancers, supporting sustained demand. Increasing access to generic imatinib formulations, especially in emerging economies, is further expanding patient reach and improving affordability, thereby strengthening market growth.

Hydraulic pump market was valued at $11.3 billion in 2025 and is projected to reach $16.63 billion by 2035, growing at a CAGR of 3.33% during the forecast period (2026-2035). The rising global infrastructure development is strengthening demand for hydraulic systems across construction, mining, and industrial applications. According to the International Energy Agency, global infrastructure investment requirements are expected to exceed $3 trillion annually through 2030, driven by urbanization and energy transition projects. Hydraulic pumps play a critical role in ensuring efficient fluid power transmission, enabling precision control, high load handling, and operational efficiency in heavy machinery. The market is witnessing steady adoption of advanced electro-hydraulic technologies as manufacturers upgrade equipment platforms.

Hunter syndrome treatment market was valued at $1.07 billion in 2025 and is projected to reach $2.15 billion by 2035, growing at a CAGR of 7.23% during the forecast period (2026–2035). The increasing prevalence of rare genetic disorders and rising focus on orphan drug development are key macro drivers supporting market growth. According to the World Health Organization, rare diseases affect approximately 400 million people globally, highlighting the significant unmet need for specialized treatments. Hunter syndrome (MPS II), a rare lysosomal storage disorder, requires long-term therapeutic intervention such as enzyme replacement therapy and gene therapy. Increasing regulatory support for orphan drugs and advancements in biotechnology are accelerating the development and commercialization of innovative treatment options.

Esomeprazole market was valued at $2.01 billion in 2025 and is projected to reach $3.62 billion by 2035, growing at a CAGR of 6.05% during the forecast period (2026–2035). The increasing global burden of gastrointestinal disorders is significantly driving demand for proton pump inhibitors, particularly esomeprazole. Rising prevalence of gastroesophageal reflux disease (GERD), peptic ulcer disease, and acid-related disorders is strengthening the need for effective acid suppression therapies across both developed and emerging markets. Additionally, increasing consumption of nonsteroidal anti-inflammatory drugs (NSAIDs) is contributing to higher incidence of gastric complications, further supporting sustained demand for esomeprazole-based treatments. 

Corticosteroids market was valued at $6.20 billion in 2025 and is projected to reach $10.29 billion by 2035, growing at a CAGR of 5.2% during the forecast period (2026–2035). The rising prevalence of chronic inflammatory and respiratory diseases is significantly strengthening demand for corticosteroid-based therapies across global healthcare systems. According to the World Health Organisation, chronic respiratory diseases such as asthma and COPD affect over 550 million people worldwide, driving sustained demand for anti-inflammatory medications, including corticosteroids. These drugs play a critical role in reducing inflammation, suppressing immune responses, and managing disease progression across multiple therapeutic areas. The increasing burden of allergic and autoimmune disorders is further accelerating market expansion.